Product
KRN8601
1 clinical trial
1 indication
Indication
Multiple Myeloma and Malignant LymphomaClinical trial
A Clinical Trial of KRN125 to Mobilize Hematopoietic Stem Cells Into Peripheral Blood in Patients With Multiple Myeloma and Malignant LymphomaStatus: Completed, Estimated PCD: 2022-10-25